Advertising

NASDAQ:ATRI

660.00
23.52 (3.70%) 1d
0
Showing 1 to 14 of 14 entries
  • «
  • 1
  • »
PAST TOP PICK
(A Top Pick Aug 25/20, Up 0%) Make niche products that larger companies don't make. Not many elective surgeries happening now, so stock down. Trying to buy as much as possible. Is a good long term hold.
Healthcare
PAST TOP PICK
(A Top Pick Aug 25/20, Up 7%) They suffered because of a lack of elective surgeries. The backlog of two to three years is going to start to put the earnings upwards. It is actually quite cheap where it stands now. The have a good history of free cash flow generation.
Healthcare
COMMENT
There are 7,000 publicly traded companies in the world, and their firm runs 20 different screens. The most important is free cash flow growth. With that, you can invest in R&D, do acquisitions, pay down debt, buy back shares, or pay a dividend. Atrion has very strong dividend increases. Small company, but really strong free cash flow characteristics.
Healthcare
TOP PICK
A leading supplier of medical devices to niche markets, like opthamology (i.e. IV tubes with clips). The share price has returned to 2017 levels, but they have new products coming out and elective surgery is coming back so demand will rise. Last week, they announced a 13% dividend increase. Strong free cash flow.
Healthcare
PAST TOP PICK
(A Top Pick Jul 29/19, Down 17%) They are in medical devices -- cardiac, eyes and fluid delivery devices. Elective surgeries have declined, but fluid delivery has continued to do well. They have been buying back shares around $630 per share, so there is good support here.
Healthcare
BUY on WEAKNESS
It is a medical device company. It is potentially an acquisition target. It has had a decent run. It is an interesting company. It is not a buy but could be in a bit more of a sell off.
Healthcare
PARTIAL BUY
A small cap medical device company, only US$400 million. They're good at what they do, but it's volatile. Use limit orders. He's owned this since $100/share, and has bought on pullbacks. They have new products in the pipe, but there was a slowdown in the supply chain recently. Dividend is growing by 10-15%. Organic revenue growth around 5%. Start with a half-position with the current toppy market.
Healthcare
PAST TOP PICK
(A Top Pick Jul 29/19, Up 10%) A small Texas company. Not in any ETFs, so this will avoid an ETF sell-off when markets panic. They are in health care. They've been very acquisitive.
Healthcare
TOP PICK
Great cash flow with little debt. Cash is his key metric. When the Russell was down 12% in 2018, ATRI was up 18%. Great long-term hold. (no price target)
Healthcare
COMMENT

Small caps tend to be less liquid and therefore may have higher betas, although this one is low at 6.1, because it doesn't trade a lot. It makes all kinds of medical devices that none of the big guys want to manufacture. A good entry point would be around $50. This is one you want to hold for the long run.

Healthcare
PAST TOP PICK

(A Top Pick Jan 15/16. Up 44.32%.) A tiny little company out of Texas that makes things in the healthcare sector that nobody else wants to create, such as little catheters, IV tubes, cases for contact lenses, etc. His fear is that this company could get bought out because the CEO is getting into his 60s, and succession would be a risk. He wouldn’t buy at this price as it is a little overpriced. Buy on weakness.

Healthcare
PAST TOP PICK

(A Top Pick April 4/16. (Actually Jan 15/16.) Up 0.65%.) A little, small medical device company that handles products that larger companies don’t want to be bothered with. It continues to grow very well in the little niches that nobody else wants to do. The dividend has been growing roughly at a 20% clip. Earnings are supposed to be between $15 and $20.

Healthcare
PAST TOP PICK

(Top Pick Jan 15/16, Up 10.30%) Small company that makes vascular clamps and pull tags on life vest. Long term growth over the last 15-20 years. No one else makes these clips. They make good margins.

Healthcare
TOP PICK

A tiny healthcare company that no US brokerage analyst covers. A quiet stock that small investors can buy. Not very liquid, but they have been around for many, many years. They make widgets in operating rooms for open-heart surgery, and the machines that moves medicine and blood flow into the heart while the surgery is going on. Growth about 7%-8% a year. Dividend yield of 1.01%.

Healthcare
Showing 1 to 14 of 14 entries
  • «
  • 1
  • »

Atrion Corp(ATRI-Q) Rating

Ranking : 4 out of 5

Bullish - Buy Signals / Votes : 1

Neutral - Hold Signals / Votes : 0

Bearish - Sell Signals / Votes : 0

Total Signals / Votes : 1

Stockchase rating for Atrion Corp is calculated according to the stock experts' signals. A high score means experts mostly recommend to buy the stock while a low score means experts mostly recommend to sell the stock.

Atrion Corp(ATRI-Q) Frequently Asked Questions

What is Atrion Corp stock symbol?

Atrion Corp is a American stock, trading under the symbol ATRI-Q on the NASDAQ (ATRI). It is usually referred to as NASDAQ:ATRI or ATRI-Q

Is Atrion Corp a buy or a sell?

In the last year, 1 stock analyst published opinions about ATRI-Q. 1 analyst recommended to BUY the stock. 0 analysts recommended to SELL the stock. The latest stock analyst recommendation is . Read the latest stock experts' ratings for Atrion Corp.

Is Atrion Corp a good investment or a top pick?

Atrion Corp was recommended as a Top Pick by on . Read the latest stock experts ratings for Atrion Corp.

Why is Atrion Corp stock dropping?

Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.

Is Atrion Corp worth watching?

1 stock analyst on Stockchase covered Atrion Corp In the last year. It is a trending stock that is worth watching.

What is Atrion Corp stock price?

On 2022-08-10, Atrion Corp (ATRI-Q) stock closed at a price of $660.